Hydrangenol inhibits lipopolysaccharide-induced nitric oxide production in BV2 microglial cells by suppressing the NF-kappa B pathway and activating the Nrf2-mediated HO-1 pathway

作者：Kim Hee Ju; Kang Chang Hee; Jayasooriya Rajapaksha Gedara Prasad Tharanga; Dilshara Matharage Gayani; Lee Seungheon; Choi Yung Hyun; Seo Yong Taek; Kim Gi Young^*

来源：International Immunopharmacology, 2016, 35: 61-69.

DOI：10.1016/j.intimp.2016.03.022

• Hydrangenol
• Nitric oxide
• Nuclear factor-kappa B
• Heme oxygenase-1
• Nuclear factor erythroid 2-related factor 2

We previously demonstrated the anti-inflammatory effect of water extract of Hydrangea macrophylla in lipopolysaccharide (LPS)-stimulated macrophage cells. Here, we investigated whether hydrangenol, a bioactive component of H. macrophylla, attenuates the expression of nitric oxide (NO) and its associated gene, inducible NO synthase (iNOS), in LPS-stimulated BV2 microglial cells. Our data showed that low dosages of hydrangenol inhibited LPS-stimulated NO release and iNOS expression without any accompanying cytotoxicity. Hydrangenol also suppressed LPS-induced nuclear translocation of nuclear factor-kappa B (NF-kappa B) subunits, consequently inhibiting DNA-binding activity of NF-kappa B. Additionally, the NF-kappa B inhibitors, pyrrolidine dithiocarbamate (PDTC) and PS-1145, significantly attenuated LPS-induced iNOS expression, indicating that hydrangenol-induced NF-kappa B inhibition might be a key regulator of iNOS expression. Furthermore, our data showed that hydrangenol suppresses NO production by inducing heme oxygenase-1 (HO-1). The presence of cobalt protoporphyrin, a specific HO-1 inducer, potently suppressed LPS-induced NO production. Hydrangenol also promoted nuclear translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) and subsequently increased its binding activity at the specific antioxidant response element sites. Additionally, transient knockdown of Nrf2 significantly downregulated hydrangenol-induced HO-1 expression, indicating that hydrangenol-induced Nrf2 is an upstream regulator of HO-1. Taken together, these data suggest that hydrangenol attenuates NO production and iNOS expression in LPS-stimulated BV2 microglial cells by inhibiting NF-kappa B activation and by stimulating the Nrf2-mediated HO-1 signaling pathway. Therefore, hydrangenol is a promising therapeutic agent for treatment of LPS-mediated inflammatory diseases.

• 出版日期2016-6